Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Beam Therapeutics
Beam Therapeutics to Participate in Upcoming May Investor Conferences
May 17, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
May 11, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
May 10, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
March 27, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer
March 21, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
March 15, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
March 01, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
February 28, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
February 07, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Progress Across Base Editing Portfolio and Outlines Key Anticipated Milestones
January 09, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Presents First In Vivo Proof of Concept Preclinical Data on Multiplex Base Edited ESCAPE Platform for Non-Genotoxic Conditioning Regimen for Patients with Sickle Cell Disease Ahead of Autologous Transplant
December 10, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022
December 02, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201
December 02, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the BofA Securities 2022 Virtual Biotech SMID Cap Conference
November 30, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease
November 14, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in Upcoming Investor Conferences
November 09, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Present New Preclinical Data Highlighting Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant at the 64th ASH Annual Meeting
November 03, 2022
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.